Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. | 50,000 | reported | 11 Jul 2025 | tx 10+365,000 |
| Alpha Cognition Inc. | 22,241 | reported | 14 Jan 2026 | tx 4+60,697 |
| GTX INC /DE/ | 2,200 | reported | 20 Jun 2024 | tx 22+2,020,656−45,980 |
| CymaBay Therapeutics, Inc. | 0 | reported | 22 Mar 2024 | tx 32+362,460−362,460 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Jan 2026 | GRANT_AWARD | Alpha Cognition Inc. | 7,241 | 0.00 USD | |
| 14 Jan 2026 | GRANT_AWARD | Alpha Cognition Inc. | 8,437 | 0.00 USD | deriv |
| 18 Aug 2025 | PURCHASE | Alpha Cognition Inc. | 15,000 | 8.49 USD | first after silence |
| 11 Jul 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 50,000 | — | |
| 11 Jul 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 50,000 | — | deriv |
| 11 Jul 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 50,000 | — | deriv |
| 10 Jun 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 40,000 | 0.00 USD | deriv |
| 07 Apr 2025 | GRANT_AWARD | Alpha Cognition Inc. | 30,019 | 0.00 USD | deriv |
| 28 Aug 2024 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 40,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | GTX INC /DE/ | 2,200 | 0.00 USD | deriv |
| 08 Apr 2024 | PURCHASE | GTX INC /DE/ | 3,086 | 8.96 USD | |
| 28 Mar 2024 | PURCHASE | GTX INC /DE/ | 6,914 | 8.48 USD | first after silence |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 30,000 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 14,010 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 25,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 67,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 32,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 49,245 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 27,705 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 18,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 7,500 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 15,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 27,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 9,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 25,000 | — | deriv |
4 purchases reported after at least 12 months of silence — most recent on 18 Aug 2025.